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Abstract: Chemical examination of the octocoral-associated Bacillus species (sp.) DT001 led to the
isolation of pumilacidins A (1) and C (2). We investigated the effect of these compounds on the
viability of Plasmodium falciparum and the mechanism of pumilacidin-induced death. The use of
inhibitors of protein kinase C (PKC) and phosphoinositide 3-kinase (PI3K) was able to prevent the
effects of pumilacidins A and C. The results indicated also that pumilacidins inhibit parasite growth
via mitochondrial dysfunction and decreased cytosolic Ca2+.
Keywords: Bacillus; surfactins; pumilacidins; coral-associated bacteria; P. falciparum; apoptosis
1. Introduction
Surfactins are cyclic lipopeptides that consist of a heptapeptide backbone and one β-hydroxyl
fatty acid with variable chain lengths (12–16 carbons) produced by members of the Bacillus genus [1–5].
These compounds display a broad spectrum of biological activities, such as antibacterial [6,7],
antifungal [8–10], antiviral and anti-ulcer [11], hemolytic [12], antitumor [13], anti-mycoplasma [14],
anti-inflammatory [15–18], and insecticidal [19], and they have neuroprotective effects [20] among other
properties that make them promising for industry, biotechnology, and pharmacy [21]. Pumilacidins
are a variant of the surfactin family that consist of a β-hydroxy fatty acid, L-glutamic acid, L-leucine,
D-leucine, L-leucine, L-aspartic acid, D-leucine, and L-isoleucine (or L-valine), and they exhibit
antiviral activity against herpes simplex virus type 1 and inhibitory activity against hog gastric
H+, K+-ATPase [11], and recently, antibacterial activity against Staphylococcus aureus [22].
In living organisms, apoptosis is defined as a caspase-dependent variant of regulated cell death,
triggered by intrinsic or extrinsic events. Apoptosis is highly controlled, but it is also reversible,
as demonstrated by the existence of metabolic checkpoints that function to reestablish homeostasis [23].
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This apoptosis-like process was described for some parasites, such as Trypanosoma and Leishmania,
as well as Plasmodium [24–27].
Intracellular signals regulating cell survival and death are now largely understood, owing to
the numerous published studies on the matter [28–30]. Of the signaling molecules, phosphoinositide
3-kinase (PI3K) is an important component in regulating the expression level and activation
of apoptosis. In a previous study, it was found that a surfactin analog isolated from Bacillus
licheniformis BC98 was a novel Plasmodium falciparum silent information regulator 2 (PfSir2)
inhibitor [31]. Sir2-like proteins are histone acetyltransferases and deacetylases that catalyze the
oxidized nicotinamide adenine dinucleotide (NAD+)-dependent deacetylation of lysine residues
in target proteins, and they have a wide range of functions in cell activities including antigenic
variation, gene silencing, cell-cycle progression, chromosome segregation, microtubule organization,
protein-aggregate transport, genome stability, DNA repair, apoptosis, and autophagy. They are also
related to aging, life-span, and metabolism studies. Moreover, some diseases like obesity, type II
diabetes, cancer, and neurodegenerative disorders are linked to them [32–34]. Even with so many
possible functions in P. falciparum, the deletion of the PfSir2 gene is not lethal to the parasite [31,35],
thus opening up the possibility of the presence of a similar gene in the Plasmodium genome, one not
yet biochemically characterized and which would be the target of the surfactins. Since surfactins
are implicated in inducing apoptosis and cell-cycle arrest in other cell types, their mechanism of
action in Plasmodium falciparum parasites is still not clear [36]. In this study, we aimed to explore the
anti-proliferative activity of the surfactins pumilacidin A (1) and pumilacidin C (2) against the malaria
parasite, Plasmodium falciparum, and its mechanism of growth inhibition at the molecular level.
2. Results
2.1. Collection and Identification of Biological Material
The strain DT001 was isolated from the octocoral Muricea fruticosa (order Alcyonacea, family
Plexauridae) collected in the surroundings of the submarine mountain Hannibal Bank in the Coiba
National Park, Veraguas, Panama, in March 2012. The bacterium was identified as Bacillus species (sp.)
based on its 16S ribosomal RNA (rRNA) gene sequence analysis.
2.2. Extraction, Isolation, and Characterization of Compounds
The strain Bacillus sp. DT001 was cultured in 10 L of M1 culture broth for 10 days in an orbital
shaker at 150 rpm at room temperature, and then extracted with ethyl acetate to obtain the organic
crude extract. The extract was fractionated using C-18 solid-phase extraction (SPE) cartridges by
eluting in a stepwise gradient of MeOH–H2O followed by reverse-phase HPLC purification to
obtain pumilacidins A (1) and C (2) (Figure 1). The structures of compounds 1–2 were deduced
by spectroscopic analyses including one- and two-dimensional (1D and 2D) NMR, tandem MS, and by
comparing (Figures S1–S18) with literature data [11,16,37,38].
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2.3. Pumilacidins Inhibit the Growth of Plasmodium falciparum Parasites without Affecting Uninfected Cells
To assess the inhibitory effect of pumilacidins A and C on the growth of Plasmodium falciparum,
parasites were treated with these compounds at different concentrations for 48 h, and a viability
assay was conducted. The IC50 value obtained when the treatment was applied in the ring stage was
15.44 µM for pumilacidin A and 19.59 µM for pumilacidin C. For the schizont stage, the corresponding
IC50 values were 8.34 µM for pumilacidin A and 7.75 µM for pumilacidin C (Table 1). These values are
in accordance with previous work [31], and indicate that pumilacidins can suppress the proliferation
of Plasmodium falciparum in a dose-dependent manner (Figure 2).
Table 1. Antiplasmodial activity of pumilacidins on different parasite stages. The data shown are from
three experiments run in duplicate. IC50—half maximal inhibitory concentration; SEM—standard error
of the mean.
Compound Parasite Stage IC50 (µM) SEM
Pumilacidin A
schizont 8.34 0.97
ring 15.44 3.9
Pumilacidin C
schizont 7.75 1.74
ring 19.59 4.4
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schizont stage parasites to ensure pronounced effects that could be recorded, with the minimum 
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those treated with pumilacidins A and C at 10 μM for 24 h underwent almost 50% inhibition of 
parasite proliferation.  
Figure 2. Effect of pumilacidins on the proliferati n of Plasmodium f lciparum. (A) Rin stage;
(B) schizont stage; (C) chloroquine (CQ) control in ring stage. Plasmodium parasites were incubated
together with pumilacidins A and C at 10, 2, 0.4, and 0.08 µM, and CQ at 1000, 10, and 0.1 nM for
48 . The proliferati n of pumilacidin-treated p rasites was measured by PicoGr en DNA fluorometric
measurement. Data represent the means ± standard error of the mean (SEM) of one representative
observation out of three experi ents perfor ed in licate. ** p < 0.01, * p < 0. 01.
For the mechanism-of-action studies, based on the screening results, we used 10 µM and schizont
stage parasites to ensure pronounced effects that could be recorded, with the minimum amount of
sample, incubating for only 24 h. As shown in Figure 3, compared with untreated cells, those treated
with pumilacidins A and C at 10 µM for 24 h underwent almost 50% inhibition of parasite proliferation.
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Figure 3. Effect of pumilacidins on the proliferation of P. falciparum. Plasmodium parasites were cultured
in the presence of pumilacidins A and C at 10 µM for 24 h. The proliferation of pumilacidin-treated
parasites was measured by flow cytometry quantifying their DNA content with Hoechst 33342 staining.
Data represent the means ± SEM of two independent observations performed in triplicate. * p < 0.05.
As pumilacidins were tested in macrophages [16], we tested the effect of pumilacidins in
uninfected red blood cells (uRBCs) and in an ther mammalian cell line, V ro c lls. Our results showed
that there was no evident negative effect agai st uRBCs. We d d not find hemolytic activity against
uninfected red blood cells when incub ted with pum lacidins A and C at 10 µM (Figure 4). To assess
any possible damag to RBCs in the form of pores in their membrane, the incorporation of propidium
i dide (PI) was monitored. W did not fi d any significant chang in the amount of PI in treated cells
in comparis n with the untreated control (Figure 5).
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Figure 5. Effect of pumilacidins on cell-membrane integrity. Infected and uninfected red blood cells
were cultured with pumilacidins A and C at 10 µM for 3 h. As a positive control, heating at 80 ◦C
was used. Integrity of the membranes was determined by the incorporation of propidium iodide (PI)
measured by flow cytometry and plotted as mean fluorescence intensity (MFI). Data represent the
means ± SEM of one representative experiment performed in triplicate. *** p < 0.001.
There was also no deleterious effect of pumilacidins A and C on normal epithelial cells. Based on
our cytotoxic assay, the IC50 values for the compounds tested on these cells were 28.42 and 26.07 µM,
respectively (Table 2).
Table 2. The cytotoxic activity of pumilacidins on African green monkey kidney epithelial cells (Vero
cells). Data are the means of one experiment run in duplicate.
Compound IC50 (µM) SE
Pumilacidin A 28.42 9.86
Pumilacid n C 26.07 10.10
2.4. Effect of Pumilacidins on the Induction of Pro-Apoptotic-Like Activity
To evaluate whether the pumilacidin-induced anti-proliferative effect was due to their triggering
of proapoptotic-like activity, some apoptotic parameters such as morphological changes and alteration
of membrane polarity were chosen for more in-depth analysis. Clear morphological changes (nuclear
condensation and the presence of perinuclear apoptotic bodies) of Plasmodium parasites treated with
pumilacidins at 10 µM were observed by conventional microscopy (Figure 6). The treatment was
performed in the schizont stage, and morphological changes were analyzed 48 h later, in the schizont
stage, where apoptotic signatures can be more easily distinguished.
Molecules 2018, 23, 2179 6 of 17
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Figure 6. Morphological changes induced by pumilacidins A and C. Panel A1 and A2: Untreated
parasites. Panel B1 and B2: P. falciparum-infected erythrocytes in the schizont stage were treated
with 10 µM pumilacidins A and C, and their morphology was analyzed 48 h after treatment through
Giemsa-stained smears.
2.5. Pumilacidin-Induced Apoptosis-Like Death through Mitochondrial Dysfunction Pathways
To determine whether pumilacidins induce the loss of mitochondrial membrane potential in
Plasmodium parasites, we examined the effect of these surfactins on their potential using the Di06 dye,
a fluorophore that accumulates rapidly and selectively inside the mitochondria depending on the
membrane potential. We found that pumilacidin treatment caused disruption of the mitochondrial
membrane potential as evidenced by a decrease in the proportion of cells with higher fluorescence
intensity. This decrease occurred in a time-dependent manner showing a decreasing tendency from 3 h
after treatment until reaching significance 9 h after treatment with surfactins (Figure 7).
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a time-dependent manner. These results rule out the involvement of reactive oxygen species in the
apoptosis-like death of malaria parasites after treatment with the surfactins.
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Figure 8. Reactive oxygen species (ROS) generation after surfactin treatment. After incubating
P. falciparum parasites in the schizont stage with pumilacidins A and C at 10 µM for different time
points, the levels of ROS were measured at 3 h (A), 6 h (B), and 9 h (C) post treatment with surfactins.
2.7. Calcium Involvement in Parasite Death after Pumilacidin Treatment
To further determine the role of Ca2+ in pumilacidin-indu d p ptosis, experiments were
performed to see whether the surfactins could change Ca2+ concentrati n fter treatment with
pumilacidins A and C at 10 µM in saponin-isolated parasites. The levels of calcium measured through
fluorescence intensity of the calcium dye fura-2-acetoxymethyl ester (FURA 2AM) were determined
at 10, 30, 60, and 90 min after the introduction of surfactins. The results showed that, 10 min after
the treatment with surfactins, there was a decrease in the amount of cytosolic calcium in the parasite
for pumilacidins A and C when compared to the untreated controls, but with higher values than
those obtained with the mitochondrial disruptor, carbonyl cyanide m-chlorophenyl hydrazone (CCCP)
(Figure 9).
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pumilacidin introduction. Samples were tested in duplicate. A representative result is shown.
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2.8. Effect of Pumilacidins on the Activation of Inositol Trisphosphate Apoptosis-Regulatory Signals
Since it was reported that some signaling enzymes, such as the phosphatidylinositol
4,5-bisphosphate 3-kinase family, are known to play a central role in regulating pro-apoptotic
processes including cell-cycle arrest, the modulatory effect of surfactins on the activation of these
enzymes was examined by inhibiting this pathway and studying the effect of surfactins on parasite
proliferation under this condition. To further assess the role of inositol triphosphate (IP3) enzymes in
the surfactin-induced proliferation decrease, the inositol triphosphate 3-kinase (IP3K)-related inhibitors,
3-methyladenine and LY29400, and a protein kinase C (PKC) inhibitor were used since PKC has some
reports of involvement with the IP3 apoptosis regulatory pathway [39] (See Table 3). The results
described in Figure 10 show that all inhibitors tested partly reversed the surfactin-induced inhibition
of growth of parasites after the treatment. The most significant reversal effect was obtained with
the inhibitor, LY29400, that inhibits PI3-kinase class I. The inhibitors at the concentration used had
no detrimental effect on parasites either in the normal proliferation or morphology, as shown in
Figures 10B and 11.
Table 3. Inositol triphosphate (IP3)-related signal transduction pathway inhibitors.
Inhibitor Nomenclature Used Target
3-Methyladenine (3MA) Inhibitor 1 Phosphatidylinositol 3-kinases (PI3Ks) I and III
LY29400 Inhibitor 2 PI3-kinase I (PI3K)
Protein kinase C (PKC) inhibitor
(bisindolylmaleimide I) Inhibitor 3 PKC
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found in the P. falciparum genome database [43]. Nonetheless, another kinase may have taken its role,
just as in plants, where it was suggested that another kinase, calcium-dependent protein kinase (CDPK),
may function as PKC [44]. Since the growth rate of parasites is found to be decreased in PKC-deficient
erythrocytes, it was also suggested that PKC from the red blood cell may be trafficked inside the
erythrocyte, influencing the invasion ability of the Plasmodium parasite through the phosphorylation of
the proteins ring-infected erythrocyte surface antigen precursor (RESA) and band 4.1, which increase
the permeability of RBCs, making it possible for the parasite to invade [45].
The effect of surfactins could be explained on the basis of stimulated Ca2+ transport out of the
cell through the plasma membrane and stimulated calcium reuptake into the ER or mitochondria.
The release of calcium through IP3 receptor 1 is closely associated with the induction of apoptosis
via the inner mitochondrial pathway. The activation of the mitochondrial pathway of apoptosis
is deeply dependent on calcium release from the ER due to stress. The release of calcium from
the ER and local interactions between the ER and mitochondria represent a key mechanism of
apoptosis regulation. The PI3K inhibitors used were chosen because they are two of the most
common PI3K inhibitors used in signaling studies. Moreover, based on our first mechanism results,
we reasoned that the PI3K signaling pathway might be involved in the apoptotic-like death that
we observed in surfactin-induced killing. The 3MA inhibitor has an inhibitory effect on class I and
III phosphatidylinositol 3-kinases (PtdIns3Ks) [46] The LY294002 inhibitor is a potent and specific
cell-permeable inhibitor of several isoforms of phosphatidylinositol 3-kinases (PI3-kinases) with IC50
values in the 1–50 µM range [47] which bind to the intracellular part of PI3K. LY294002 competitively
inhibits ATP binding to the catalytic intracellular subunit of PI3-kinases and does not inhibit PI4-kinase,
diacylglycerol (DAG)-kinase, PKC, protein kinase A (PKA), mitogen-activated protein kinase (MAPK),
S6 kinase, epidermal growth factor receptor (EGFR), or cellular (c)-src tyrosine kinases and rabbit
kidney ATPase. The inhibitor (bisindolylmaleimide I) used in this study targets all forms of PKC (α,
βI, βII, and γ). Recently, the role of phosphorylation in PKC activation was examined, and it provided
a clear link between PI3K/PtdIns-3,4,5-P3 signaling and PKC function [48]. Together, both inhibitors
with their effect point to a role of PI3K in the chain of events that leads to apoptosis-like death.
4. Materials and Methods
4.1. General Experimental Procedures
Optical rotations were measured in MeOH with a JASCO P-2000 digital polarimeter
(JASCO, Easton, MD, USA). Ultraviolet (UV) spectra were recorded using a Shimadzu UV-Vis-
spectrophotometer model UV-2401 (PC) (Shimadzu, Columbia, MD, USA). NMR spectra were recorded
on an Eclipse 400 MHz spectrometer (JEOL, Peabody, MA, USA). Chemical shifts were calibrated
internally based on the signal for the residual solvent in which the sample was dissolved (d-MeOH,
δH 3.34, δC 49.86). Pre-fraction of the bacterial extract was carried out using SupelCleanTM C-18
solid-phase extraction cartridges (Supelco® Analytical, Bellefonte, PA, USA). HPLC purification was
carried out using an 1100 HPLC system (Agilent, Santa Clara, CA, USA) equipped with a quaternary
pump, an Agilent 1200 Series diode array detector, and a reverse-phase silica gel column (Agilent
Zorbax® SB-C18, 4.6 mm × 150 mm). Tandem mass spectrometry (MS/MS) analysis of bacterial
extracts and compounds was performed in a 6.42 T Thermo Finnigan LTQ-FT-ICR mass spectrometer
(Thermo-Electron Corporation, San Jose, CA, USA) using a TriVersa NanoMate chip-based electrospray
ionization source (Advion Biosystems, Ithaca, NY, USA) and an Agilent 1290 Infinity LC System
(Agilent Technologies, Santa Clara, CA, USA) coupled to a micrOTOF-QIII mass spectrometer (Bruker
Daltonics, Billerica, MA, USA) supplied with an electrospray ionization (ESI) source. Flow cytometry
was performed in a CyFlow® Space cytometer (Sysmex-Partec, Goerlitz, Germany).
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4.2. Biological Material Collection and Identification
A healthy specimen of the octocoral Muricea fruticosa was collected by hand using scuba apparatus
in the vicinity of the submarine mountain Hannibal Bank in the Coiba National Park on the Pacific
coast of Veraguas, Panama in 2012. The coral specimen was identified as Muricea fruticosa (Verril 1869),
based on its morphology. For the isolation of the coral-associated bacteria, we followed a protocol
previously reported [49–51], using the nutrient medium M1 (10 g of potato starch, 4 g of yeast
extract, 2 g of peptone from potatoes, and 18 g of agar in 1 L of natural seawater). Strain DT001 was
further isolated from the collection plate and successively re-plated until a pure strain was obtained.
The taxonomic identification of strain DT001 was carried out by the sequencing of the 1462 bp of
16S rRNA gene and compared to the nucleotide database of the National Center for Biotechnology
Information (NCBI) using the Basic Local Alignment Search Tool (BLAST®) and showed 99% similarity
with Bacillus sp. The sequence of strain DT001 was deposited in GenBank under accession number
MG018253. A reference specimen of the octocoral (GLCO-100312-21) and bacterial strain Bacillus sp.
DT001 are deposited at the INDICASAT Center for Biodiversity and Drug Discovery (CBDD).
4.3. Fermentation, Extraction, and Isolation of Surfactins
Bacillus sp. DT001 was inoculated in ten Erlenmeyer flasks containing 1 L of liquid medium
M1. Erlenmeyer flasks were placed in an orbital shaker at 150 rpm at room temperature. After ten
days, the culture broth was extracted with ethyl acetate (4 × 500 mL), and then, the organic layer was
washed with distilled water (4 × 500 mL) to remove traces of the culture media. The organic extract
was dried under reduced pressure to yield 281 mg of crude extract.
The extract (281 mg) was fractionated using C-18 solid-phase extraction cartridges eluting in
a stepwise gradient of 20%, 40%, 60%, 80%, and 100% MeOH in water to yield five fractions (A–E).
Fraction E (134.1 mg) was subjected to reverse-phase HPLC purification (Agilent Zorbax® SB-C18
4.6 mm × 150.0 mm column, gradient from 80 to 95% MeOH/H2O for 50 min, then 95% MeOH/H2O
for five minutes, and returning to the initial gradient 80% MeOH/H2O for ten minutes at 1.0 mL/min)
to yield pumilacidin A (1) (36.2 mg, tR 43.8 min) and pumilacidin C (2) (15.3 mg, tR 50.6 min).
Pumilacidin A (1): white solid; [α]D25—11.2 (MeOH, c 0.28); UV (MeOH) λmax (log ε) 206 nm (6.99);
1H-NMR (CD3OD, 400 MHz) 5.20 (1H, br), 4.71 (1H, br), 4.51, (1H, br), 4.48, (1H, br), 4.47, (1H, br),
4.37 (1H, br), 4.35 (1H, br), 4.29 (1H, Br), 2.66 (1H, dd, J = 4.4, 14.3 Hz), 2.48 (1H, dd, J = 8.0, 14.6 Hz),
2.10 (1H, br), 1.99, (1H, br), 1.96 (1H, br), 1.78, (1H), 1.68 (1H, br), 1.66 (8H, m), 1.55 (1H, br), 1.36 (4H, br),
1.34 (1H, br), 1.32 (14H, br), 1.25 (2H, br), 1.22 (2H, br), 0.99 (9H, br), 0.96 (9H, br), 0.95 (6H, br), 0.94 (6H,
br), 0.91 (3H, br), 0.90 (3H, br); 13C-NMR (CD3OD, 100 MHz) 176.4 (C=O), 176.3 (C=O), 175.9 (C=O),
175.8 (C=O), 175.6 (C=O), 174.6 (C=O), 174.5 (C=O), 173.8 (C=O), 173.6 (C=O), 173.3 (C=O), 74.8 (CH–O),
59.2 (CH–N), 55.1 (CH–N), 55.0 (CH–N), 54.5 (CH–N), 54.4 (CH–N), 53.9 (CH–N), 52.7 (CH–NH),
43.1 (CH2), 42.5 (CH2), 42.2 (CH2), 42.0 (CH2), 41.8 (CH2), 41.1 (CH2), 39.2 (CH), 38.6 (CH2), 36.5 (CH),
36.2 (CH2), 31.9 (CH2), 31.8 (CH2), 31.6 (CH2), 31.4 (CH2), 31.4 (CH2), 31.2 (CH2), 30.0 (CH), 29.4 (CH2),
29.0 (CH2), 27.2 (CH2), 27.0 (CH2), 26.8 (CH), 26.8 (CH), 26.6 (CH), 24.4 (CH3), 24.2 (CH3), 24.1 (CH3),
23.9 (CH3), 23.4 (CH3), 23.2 (CH3), 22.9 (CH3), 22.5 (CH3), 20.5 (CH3), 17.0 (CH3), 12.7 (CH3), 12.6 (CH3);
HRESITOF-MS m/z 1050.7030 [M + H]+ (calculated for C54H96N7O13).
Pumilacidin C (2): white solid; [α]D25—13.1 (MeOH, c 0.7); UV (MeOH) λmax (log ε) 203 nm (7.05);
1H-NMR (CD3OD, 400 MHz) 5.21 (1H, br), 4.70 (1H, br), 4.51 (1H, br), 4.47 (1H, br), 4.38 (1H, br),
4.37 (1H, m), 4.36 (1H, br), 4.28 (1H, br), 2.65 (1H, dd, J = 3.7, 12.9 Hz), 2.47 (1H, dd, J = 8.1, 14.3 Hz),
2.10 (1H, m), 1.98 (1H, m), 1.97 (1H, m), 1.78 (1H, br), 1.68 (1H, br), 1.66 (8H, m), 1.55 (1H, br), 1.36 (4 H,
br m), 1.34 (1H, br), 1.32 (18H, br m), 1.25 (2H, br), 1.22 (2H, br), 1.00 (9H, br), 0.97 (9H, br), 0.95 (3H,
br), 0.94 (9H, br), 0.92 (3H, br), 0.90 (3H, br); 13C-NMR (CD3OD, 100 MHz) 176.3 (C=O), 175.8 (C=O),
175.6 (C=O), 174.6 (C=O), 174.6 (C=O), 174.6 (C=O), 173.8 (C=O), 173.6 (C=O), 173.3 (C=O), 173.3 (C=O),
74.8 (CH–O), 59.2 (CH–N), 55.1 (CH–N), 55.1 (CH–N), 54.6 (CH–N), 54.5 (CH–N), 53.9 (CH–N),
52.8 (CH–N), 43.1 (CH2), 42.5 (CH2), 42.3 (CH2), 42.0 (CH2), 41.8 (CH2), 41.1 (CH2), 39.2 (CH),
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38.6 (CH2), 36.5 (CH), 36.2 (CH2), 31.9 (CH2), 31.9 (CH2), 31.6 (CH2), 31.6 (CH2), 31.6 (CH2), 31.4 (CH2),
31.4 (CH2), 31.2 (CH2), 30.0 (CH), 29.4 (CH2), 29.0 (CH2), 27.2 (CH2), 27.0 (CH2), 26.9 (CH), 26.8 (CH),
26.7 (CH), 24.4 (CH3), 24.2 (CH3), 24.1 (CH3), 23.9 (CH3), 23.4 (CH3), 23.2 (CH3), 23.0 (CH3), 22.5 (CH3),
20.5 CH3), 17.0 (CH3), 12.7 (CH3), 12.6 (CH3); HRESITOF-MS m/z 1078.7390 [M + H]+ (calculated for
C56H100N7O13).
4.4. Tandem Mass Spectrometry Experiments
For the IT-FTICRMS analysis, the bacterial extracts were diluted 1:10 in the electrospray mixture
(49.5% MeOH, 49.5% H2O, and 1% formic acid) and directly infused into the mass spectrometer
as previously described [52]. For ESI-Q-TOF-MS analysis, extracts were diluted in methanol and
analyzed using a Kinetex® 1.7 µm, C18, 100 Å LC column 50 × 2.1 mm (Phenomenex®, Torrance,
CA, USA). The gradient for the chromatographic analysis was carried out using a step (UPLC) run
of methanol in acidified water (99.9% water and 0.1% formic acid), 7-min gradient from 90:10%
MeOH/H2O to 100% MeOH, then 100% MeOH for 9 min, and returning to the initial condition 90:10%
MeOH/H2O for 1 min at a flow rate of 0.3 mL/min throughout the run. MS spectra were acquired in
positive ion mode in the range of 50–2250 m/z using data-dependent MS/MS fragmentation previously
described [53]. Prior to collecting the data, an external calibration was performed using an Agilent
ESI-L Low-Calibration Tuning Mix, and, throughout the runs, we used either hexakis (1H, 1H,
2H-difluoroethoxy), phosphazene (m/z 622.0290 [M + H]+) (Synquest Laboratories, Alachua, FL, USA),
or reserpine (m/z 609.2807 [M + H]+) (Sigma-Aldrich, St. Louis, MO, USA) for lock mass calibration.
4.5. Parasites and Cultures
The malaria parasite strain HB3 of P. falciparum was cultured following the method described
by Haynes et al. [54] with some modifications. In brief, O+ erythrocytes were used in a complete
medium that consisted of Roswell Park Memorial Institute medium (RPMI-1640) supplemented
with 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.2% sodium bicarbonate,
and 10% human serum. Blood was obtained from donors following the protocol approved by the
Gorgas Memorial Institute bioethics committee. Cultures were maintained at 37 ◦C in a gas mixture
of 5% CO2, 5% O2, and 90% N2 at 2% hematocrit, and synchronized with 0.3 M alanine and thermal
cycling as described by Almanza et al. [55].
4.6. Cell Viability Assays
Vero epithelial cells (African monkey kidney epithelial cells) were seeded in 96-well plates
using RPMI-1640 medium (Sigma-Aldrich, USA) supplemented with 10% fetal bovine serum (FBS;
Gibco, Invitrogen, Carlsbad, CA, USA) and 1% penicillin/streptomycin (stock mix at 10,000 units
penicillin and 10 mg streptomycin per mL in 0.9% NaCl). The assays were based on those described by
Mosmann et al. [56]. Briefly, cells were allowed to grow for 24 h before adding pumilacidin samples.
A negative control without any sample, but with an equal volume of the vehicle, was placed in all
plates and counted as 100% growth. All samples were incubated for three days before staining and
examining for the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
after incubating it with the cells for a period of four hours. The ELISA plate reader used to measure
color was used at a wavelength of 570 nm. The IC50 was calculated using the Data Analysis Wizard
complement of Excel 2000 (Microsoft, Seattle, WA, USA).
4.7. IC50 Calculation for Pumilacidins A and C
The IC50 of the compounds was calculated using four concentrations of surfactin samples (10, 2,
0.4, and 0.08 µM) using chloroquine as a positive control (CQ) (1000, 100, and 0.1 nM) and parasites at
two different stages (ring stage 6–14 h, and schizont stage 38–48 h post invasion). Parasite cultures
were placed in 96-well plates and pumilacidins were added and incubated for 48 h. After this period,
a mix of the PicoGreen DNA fluorescent dye (Invitrogen, Carlsbad, CA, USA) was added to a final
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concentration of 1%, and after 30 min incubation, the signal was monitored on a fluorescence plate
reader as described in Corbett et al. [57] The IC50 was calculated using the Data Analysis Wizard
complement of Excel 2000 (Microsoft, Seattle, WA, USA).
4.8. Anti Plasmodium Assays
Following treatment with 10 µM of pumilacidins, schizont-synchronized cultures (between
38–48 h post invasion) with 2% parasitemia were seeded in 96-well plates for 24 h. For parasite
morphology analysis, Giemsa-stained thin smears were prepared from each well and the number of
infected erythrocytes in at least 1000 erythrocytes was determined by light microscopy after blinding
the slides to the microscopist.
To determine viability, we analyzed the morphology of the parasites under a microscope and
measured the parasitemia using flow cytometry, staining with 2 µg/mL Hoechst 33342 (Invitrogen,
Carlsbad, CA, USA) prior to fixation with 4% paraformaldehyde. The flow cytometry analysis was
carried out by exciting the samples with a UV laser. The data were analyzed with FloMax® software
version 2.7 (Quantum Analysis GbmH, Münster, Germany). A target gate was selected after analyzing
uninfected erythrocytes. The fluorescence-positive events in that gate were taken as infected parasites.
4.9. Hemolysis Assay
The test was performed in 96-well plates following the method described by Costa-Lotufo et al. [58]
with some modifications. The negative control contained only red blood cells in RPMI medium.
The compounds were tested at the highest concentration used in this work (10 µM). As a positive
control, 20 µL of 0.1% Triton X-100 (in RPMI) was used to obtain 100% hemolysis. Compounds
were incubated for 24 h at 37 ◦C and centrifuged. The supernatant was removed, and the released
hemoglobin was measured spectroscopically for its absorbance at 415 nm.
4.10. Propidium Iodide (PI) Incorporation Assay
The protocol followed was as per the manufacturer’s instructions (BD PharmingenTM). In brief,
200 µL of parasite culture at 2% parasitemia and 2% hematocrit, or 200 µL of red blood cells at 2%
hematocrit were incubated with pumilacidin compounds for 3 h at 37 ◦C. Untreated samples were kept
in the same plate. After incubation, 2 µL of PI was added with gentle homogenization and incubated for
15 min at room temperature under dark conditions. Fluorescence was read in a plate-ready fluorometer
at excitation and emission wavelengths of 485/20 and 645/40 nm, respectively.
4.11. Mitochondrial Membrane Potential (∆ψ) Measurements in P. falciparum
Changes in membrane potential were measured by staining P. falciparum cultures with the
DiOC6(3) dye at 10 nM (Thermo Fisher, Waltham, MA, USA) using flow cytometry. Samples were
incubated at 37 ◦C for 45 min in the dark. Following incubation, cells were washed and suspended
in 200 µL of phosphate-buffered saline (PBS) and analyzed by flow cytometry immediately after.
The mitochondrial membrane disrupter, CCCP (50 µM final concentration), incubated for 1 h, was used
as a positive control. The green fluorescence intensity of DiOC6-stained cells was calculated using FCS
Express 4 (De Novo Software, Glendale, CA, USA). As a control, uninfected red blood cells were used
in all treatments applied and their signal subtracted from the signal of the infected red blood cells [59].
4.12. Intracellular Reactive Oxygen Species (ROS) Production in P. falciparum
Intracellular ROS formation was measured by flow cytometry with chloromethyl
dichlorodihydrofluorescein diacetate (CM-H2DCFDA; Molecular Probes®) reactive dye. Hydrogen
peroxide, a potent oxygen radical inducer, was used as a positive control at a final concentration of
100 µM. The level of ROS present was inferred through the amount of oxidized DCF [60]. As a control,
uninfected red blood cells were used in all treatments applied. P. falciparum cultures at 2% parasitemia
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were incubated for 30 min at room temperature in the dark with PBS containing 10 µM CM-H2DCFDA.
Cultures were washed once with PBS, resuspended in RPMI-1640, and allowed to recover for 30 min
in a 37 ◦C incubator. After incubation, dye-preloaded cultures were incubated with pumilacidins A
and C at 10 µM for 3, 6 and 9 h. The intracellular ROS production was measured by flow cytometry
with a 488-nm argon laser as a light source. Experiments were repeated at least two times, in duplicate,
and the results presented are representative of these experiments.
4.13. Calcium Measurements
FURA 2AM, a membrane-permeable calcium indicator fluorescent probe, was used to study
changes in parasite cytosolic calcium after treatment with pumilacidins. Parasites were isolated from
RBCs using 0.05% saponin, and were stained with 10 µM Fura 2 AM in ringer’s solution and 0.01%
pluronic acid for 2 h at 37 ◦C in the dark. After the 2-h incubation, cells were centrifuged at 2000× g for
1 min, washed with PBS once, and resuspended in 175 µL of RPMI and 25 µL of pumilacidin samples in
a final concentration of 10 µM. After this, fluorescence was measured in the fluorometer. The calcium
levels, obtained by measuring cell fluorescence intensity at excitation and emission wavelengths of 360
and 510 nm, respectively, were determined at 10, 30, 60, and 90 min after introduction of surfactins.
4.14. Transduction Pathways
Three different inhibitors of growth signal transduction through inhibition of the IP3 signaling
pathway were used: 3MA 0.2 µM (SIGMA); LY29400 5 µM (SIGMA); bisindolylmaleimide I (PKC
inhibitor) 4 µg/mL (Abcam, Cambridge, MA, USA). All inhibitors were diluted in culture media.
Parasites were pre-incubated with inhibitors for 3 h, then washed and resuspended in RPMI media
supplemented with 10% serum before being exposed to standard treatment with 10 µM pumilacidin.
Control samples containing the inhibitors, but not pumilacidins, were used. After 24 h of incubation at
37 ◦C, the parasitemia was measured by flow cytometry with Hoechst H33342 staining at 2 µg/mL,
and their morphology was analyzed by Giemsa smears.
Supplementary Materials: The following are available online, Figures S1 to S18.
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